Guggenheim Sticks to Their Hold Rating for EyePoint Pharmaceuticals (EYPT)
at www.tipranks.com (Mon, 16-Nov 8:15 AM)
EyePoint Pharma Earnings Call: DME Focus After Wet AMD Setback
at www.tipranks.com (Sat, 14-Nov 11:58 PM)
at www.tipranks.com (Fri, 13-Nov 9:40 AM)
RBC Capital Remains a Hold on EyePoint Pharmaceuticals (EYPT)
at www.tipranks.com (Fri, 13-Nov 9:37 AM)
DURAVYU’s Phase 3 LUGANO Results Reveal Compelling Efficacy and Reduced Treatment Burden in Wet AMD
Market Chameleon (Tue, 18-Aug 9:55 AM)